P1‐369: The impaired suppression function of peripheral blood CD4 ⁺ CD ^25hi regulatory T cells in patients with Alzheimer's disease

Jun Xu,Yin Hong,Wei Shen,Ling-Ling Wang,Qing Di,Ying-Dong Zhang,Yong-An Sun,Wu-Hua Xu,Xi-Quan Hu

DOI: https://doi.org/10.1016/j.jalz.2008.05.951

2008-01-01

Abstract:New evidence showed that the bone-marrow derived microglia clear amyloid to slow down the progression of Alzheimer s disease. However, microglia activation in the brain is the inflammatory biomarker of AD neuropathology and clinical dementia. It is unclear if the regulatory T cells (Tregs) be involved to balance the overactivated immune system. We investigated the suppressive function of blood-derived regulatory T cells in patients with Alzheimer s disease (AD). The T lymphocytes subset separated from AD were compared to those of elderly controls. The CD4+CD25hi T regulatory cells were purified by cell sorter. The secretion of TGF, and IL-10 were measured by ELISA. The direct suppression effect of CD4+CD25hi T regulatory cells on T lymphocytes proliferation were performed by the mixed lymphocytes reaction andmeasured by 3H-Thymidine radioactive assay. There was no significant differences were found in T lymphocyte subpopulations including CD4+CD25hi T regulatory cells between AD and control groups, and the secretion of TGF and IL-10 were similar. However, it showed a 50% decrease in the suppression of CD4+CD25hi T regulatory cells of AD (AD-Tregs) on T cells from the same patient (AD-T cells) compared with Tregs of control group (Con-Tregs) on Con-T cells (p<0.05). The inhibition of proliferation of AD-T cells by Con-Tregs showed 5 folder than Con-T cells by AD-Tregs (p<0.01). We demonstrate the impaired suppressive activities of CD4+CD25hi T regulatory cells in patients with AD. The novel finding indicates the deficit on cell-cell contact between immune cells in AD.